List of Tables
Summary Table: Global Market for IV Therapy and Venous Access Devices, by Product Type, Through 2029
Table 1: History of IV Therapy, 1628-2007
Table 2: Common Examples of General IV Solutions
Table 3: Number and Percentage of People 65 and over, by Development Group, 2023 and 2050
Table 4: Number of Persons 65 and over, by WHO Region, 2019 and 2050
Table 5: Projected Number of U.S. Adults 50 and Older with One or More Chronic Condition, 2020-2050
Table 6: Major Recalled Products in 2023, FDA
Table 7: Global Market for IV Therapy and Venous Access Devices, by Product Type, Through 2029
Table 8: Global Market for IV Solutions and Sets, by Region, Through 2029
Table 9: Global Market for IV Solutions and Sets, by Type, Through 2029
Table 10: Global Market for General IV Solutions and Sets, by Region, Through 2029
Table 11: Global Market for Parenteral Nutrition IV Solutions and Sets, by Region, Through 2029
Table 12: Global Market for Premixed Drug IV Solutions, by Region, Through 2029
Table 13: Global Market for Other IV Solutions and Sets, by Region, Through 2029
Table 14: Global Market for Infusion Pumps, by Region, Through 2029
Table 15: Global Market for Infusion Pumps, by Type, Through 2029
Table 16: Global Market for General Infusion Pumps, by Region, Through 2029
Table 17: Global Market for Specialized Infusion Pumps, by Region, Through 2029
Table 18: Global Market for Portable and Disposable Infusion Pumps, by Region, Through 2029
Table 19: Global Market for Implantable Infusion Pumps, by Region, Through 2029
Table 20: Global Market for Venous Access Devices (IV Catheters), by Region, Through 2029
Table 21: Global Market for Venous Access Devices (IV Catheters), by Type, Through 2029
Table 22: Global Market for PIVCs, by Region, Through 2029
Table 23: Global Market for CVCs, by Region, Through 2029
Table 24: Global Market for IV Therapy and Venous Access, by Application, Through 2029
Table 25: Global Market for Hospital-based IV Therapy and Venous Access Products, by Region, Through 2029
Table 26: Barriers and Facilitators to the Uptake of IV Therapies in Ambulatory Patients, 2024
Table 27: Global Market for IV Therapy and Venous Access Products for Use in Alternative Care Settings, by Region, Through 2029
Table 28: Global Market for Home Healthcare-based IV Therapy and Venous Access Products, by Region, Through 2029
Table 29: Global Market for IV Therapy and Venous Access Devices, by Region, Through 2029
Table 30: North American Market for IV Therapy and Venous Access, by Product, Through 2029
Table 31: North American Market for IV Solutions and Sets, by Type, Through 2029
Table 32: North American Market for Infusion Pumps, by Type, Through 2029
Table 33: North American Market for Venous Access Devices (IV Catheters), by Type, Through 2029
Table 34: North American Market for IV Therapy and Venous Access, by Application, Through 2029
Table 35: North American Market for IV Therapy and Venous Access, by Country, Through 2029
Table 36: U.S. Market for IV Therapy and Venous Access, by Product, Through 2029
Table 37: U.S. Market for IV Therapy and Venous Access, by Application, Through 2029
Table 38: Canadian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 39: Canadian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 40: Mexican Market for IV Therapy and Venous Access, by Product, Through 2029
Table 41: Mexican Market for IV Therapy and Venous Access, by Application, Through 2029
Table 42: European Market for IV Therapy and Venous Access, by Product, Through 2029
Table 43: European Market for IV Solutions and Sets, by Type, Through 2029
Table 44: European Market for Infusion Pumps, by Type, Through 2029
Table 45: European Market for Venous Access Devices (IV Catheters), by Type, Through 2029
Table 46: European Market for IV Therapy and Venous Access, by Application, Through 2029
Table 47: European Market for IV Therapy and Venous Access, by Country, Through 2029
Table 48: U.K. Market for IV Therapy and Venous Access, by Product, Through 2029
Table 49: U.K. Market for IV Therapy and Venous Access, by Application, Through 2029
Table 50: French Market for IV Therapy and Venous Access, by Product, Through 2029
Table 51: French Market for IV Therapy and Venous Access, by Application, Through 2029
Table 52: Italian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 53: Italian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 54: Leading Causes of Germany’s Disease Burden, by DALYs (Level 3), 2022
Table 55: German Market for IV Therapy and Venous Access, by Product, Through 2029
Table 56: German Market for IV Therapy and Venous Access, by Application, Through 2029
Table 57: Spanish Market for IV Therapy and Venous Access, by Product, Through 2029
Table 58: Spanish Market for IV Therapy and Venous Access, by Application, Through 2029
Table 59: Rest of European Market for IV Therapy and Venous Access, by Product, Through 2029
Table 60: Rest of European Market for IV Therapy and Venous Access, by Application, Through 2029
Table 61: Asia-Pacific Market for IV Therapy and Venous Access, by Product, Through 2029
Table 62: Asia-Pacific Market for IV Solutions and Sets, by Type, Through 2029
Table 63: Asia-Pacific Market for Infusion Pumps, by Type, Through 2029
Table 64: Asia-Pacific Market for Venous Access Devices, by Type, Through 2029
Table 65: Asia-Pacific Market for IV Therapy and Venous Access, by Application, Through 2029
Table 66: Asia-Pacific Market for IV Therapy and Venous Access, by Country, Through 2029
Table 67: Chinese Market for IV Therapy and Venous Access, by Product, Through 2029
Table 68: Chinese Market for IV Therapy and Venous Access, by Application, Through 2029
Table 69: Indian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 70: Indian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 71: Japanese Market for IV Therapy and Venous Access, by Product, Through 2029
Table 72: Japanese Market for IV Therapy and Venous Access, by Application, Through 2029
Table 73: Approved Substitute Overseas-Registered IV Fluids Under Section 19A of the Therapeutic Goods Act 1989 for 2025
Table 74: Australian Market for IV Therapy and Venous Access, by Product, Through 2029
Table 75: Australian Market for IV Therapy and Venous Access, by Application, Through 2029
Table 76: South Korean Market for IV Therapy and Venous Access, by Product, Through 2029
Table 77: South Korean Market for IV Therapy and Venous Access, by Application, Through 2029
Table 78: Rest of Asia-Pacific Market for IV Therapy and Venous Access, by Product, Through 2029
Table 79: Rest of Asia-Pacific Market for IV Therapy and Venous Access, by Application, Through 2029
Table 80: RoW Market for IV Therapy and Venous Access, by Product, Through 2029
Table 81: RoW Market for IV Solutions and Sets, by Type, Through 2029
Table 82: RoW Market for Infusion Pumps, by Type, Through 2029
Table 83: RoW Market for Venous Access Devices, by Type, Through 2029
Table 84: RoW Market for IV Therapy and Venous Access, by Application, Through 2029
Table 85: ESG Steps Taken by Leading Companies, 2023
Table 86: ESG Risk Rankings for IV Therapy and Venous Access Manufacturing Firm, 2023
Table 87: Mergers and Acquisitions in the IV Therapy and Venous Access Industry, 2021-2024
Table 88: Strategic Alliances in the IV Therapy and Venous Access Market, 2021-2024
Table 89: Information Sources in this Report
Table 90: Abbreviations Used in This Report
Table 91: AngioDynamics: Company Snapshot
Table 92: AngioDynamics: Financial Performance, FY 2022 and 2023
Table 93: AngioDynamics: Product Portfolio
Table 94: AngioDynamics: News/Key Developments, 2023 and 2024
Table 95: Baxter: Company Snapshot
Table 96: Baxter: Financial Performance, FY 2022 and 2023
Table 97: Baxter: Product Portfolio
Table 98: Baxter: News/Key Developments, 2024
Table 99: B. Braun SE: Company Snapshot
Table 100: B. Braun SE: Financial Performance, FY 2022 and 2023
Table 101: B. Braun SE: Product Portfolio
Table 102: B. Braun SE: News/Key Developments, 2022-2024
Table 103: BD: Company Snapshot
Table 104: BD: Financial Performance, FY 2023 and 2024
Table 105: BD: Product Portfolio
Table 106: BD: News/Key Developments, 2022-2024
Table 107: Cardinal Health: Company Snapshot
Table 108: Cardinal Health: Financial Performance, FY 2022 and 2023
Table 109: Cardinal Health: Product Portfolio
Table 110: Cardinal Health: News/Key Developments, 2024
Table 111: Cook: Company Snapshot
Table 112: Cook: Product Portfolio
Table 113: Cook: News/Key Developments, 2024
Table 114: Fresenius SE & Co. KGaA: Company Snapshot
Table 115: Fresenius SE & Co. KGaA: Financial Performance, FY 2022 and 2023
Table 116: Fresenius SE & Co. KGaA: Product Portfolio
Table 117: Fresenius SE & Co. KGaA: News/Key Developments, 2023 and 2024
Table 118: ICU Medical Inc.: Company Snapshot
Table 119: ICU Medical Inc.: Financial Performance, FY 2022 and 2023
Table 120: ICU Medical Inc.: Product Portfolio
Table 121: ICU Medical Inc.: News/Key Developments, 2022-2024
Table 122: Integrated Medical Systems Inc.: Company Snapshot
Table 123: Integrated Medical System Inc.: Product Portfolio
Table 124: Integrated Medical Systems Inc.: News/Key Developments, 2023 and 2024
Table 125: IRadimed Corp.: Company Snapshot
Table 126: IRadimed Corp.: Financial Performance, FY 2022 and 2023
Table 127: IRadimed Corp.: Product portfolio
Table 128: IRadimed Corp.: News/Key Developments, 2023
Table 129: Medtronic: Company Snapshot
Table 130: Medtronic: Financial Performance, FY 2022 and 2023
Table 131: Medtronic: Product Portfolio
Table 132: Medtronic: News/Key Developments, 2022 and 2023
Table 133: Pfizer Inc.: Company Snapshot
Table 134: Pfizer Inc.: Financial Performance, FY 2022 and 2023
Table 135: Pfizer Inc.: Product Portfolio
Table 136: Pfizer Inc.: News/Key Developments, 2022-2024
Table 137: Terumo Corp.: Company Snapshot
Table 138: Terumo Corp.: Financial Performance, FY 2022 and 2023
Table 139: Terumo Corp.: Product Portfolio
Table 140: Terumo Corp.: News/Key Developments, 2023 and 2024
Table 141: Vygon SAS: Company Snapshot
Table 142: Vygon SAS: Product Portfolio
Table 143: Wellmed International Industries Pvt. Ltd.: Company Snapshot
Table 144: Wellmed International Industries Pvt. Ltd.: Product Portfolio
List of Figures
Summary Figure: Global Market for IV Therapy and Venous Access Devices, by Product Type, 2021-2029
Figure 1: Snapshot of the Market Dynamics for IV Therapy and Venous Access Devices
Figure 2: Distribution of New Cases of Cancer, by WHO Region, 2022
Figure 3: Distribution of Cancer Mortality Cases, by WHO Region, 2022
Figure 4: Global Market Shares of IV Therapy and Venous Access Devices, by Product Type, 2023
Figure 5: Global Market Shares of IV Solutions and Sets, by Type, 2023
Figure 6: Global Market Shares of Infusion Pumps, by Type, 2023
Figure 7: Global Market Shares of Venous Access Devices (IV Catheters), by Type, 2023
Figure 8: Global Market Shares of IV Therapy and Venous Access, by Application, 2023
Figure 9: Global Market Shares of IV Therapy and Venous Access Devices, by Region, 2023
Figure 10: North American Market Shares of IV Therapy and Venous Access, by Country, 2023
Figure 11: European Market Shares of IV Therapy and Venous Access, by Country, 2023
Figure 12: Asia-Pacific Market Shares of IV Therapy and Venous Access, by Country, 2023
Figure 13: 2024 Progress Assessment: Tracking the Sustainable Development Goals
Figure 14: Patents Documented, by Owner, January 2021 to November 2024
Figure 15: Share of Patents Documented, by Jurisdiction, January 2021 to November 2024
Figure 16: Patents Documented Over Time, January 2010 to November 2024
Figure 17: Leading Companies’ Shares of Global Market for IV Therapy and Venous Access Devices, 2023
Figure 18: AngioDynamics: Revenue Shares, by Business Unit, FY 2023
Figure 19: AngioDynamics: Revenue Shares, by Country/Region, FY 2023
Figure 20: Baxter: Revenue Shares, by Business Unit, FY 2023
Figure 21: Baxter: Revenue Shares, by Country/Region, FY 2023
Figure 22: B. Braun SE: Revenue Shares, by Business Unit, FY 2023
Figure 23: B. Braun SE: Revenue Shares, by Country/Region, FY 2023
Figure 24: BD: Revenue Shares, by Business Unit, FY 2024
Figure 25: BD: Revenue Shares, by Country/Region, FY 2024
Figure 26: Cardinal Health: Revenue Shares, by Business Unit, FY 2023
Figure 27: Cardinal Health: Revenue Shares, by Country/Region, FY 2023
Figure 28: Fresenius SE & Co. KGaA: Revenue Shares, by Business Unit, FY 2023
Figure 29: Fresenius SE & Co. KGaA: Revenue Shares, by Country/Region, FY 2023
Figure 30: ICU Medical Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 31: ICU Medical Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 32: IRadimed Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 33: IRadimed Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 34: Medtronic: Revenue Shares, by Business Unit, FY 2023
Figure 35: Medtronic: Revenue Shares, by Country/Region, FY 2023
Figure 36: Pfizer Inc.: Revenue Shares, by Business Unit, FY 2023
Figure 37: Pfizer Inc.: Revenue Shares, by Country/Region, FY 2023
Figure 38: Terumo Corp.: Revenue Shares, by Business Unit, FY 2023
Figure 39: Terumo Corp.: Revenue Shares, by Country/Region, FY 2023
Figure 40: Vygon SAS: Revenue Shares, by Business Unit, FY 2023